Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
62 participants
INTERVENTIONAL
2014-11-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is anticipated that this service will
* Ensure continuity of pharmaceutical care for patients post discharge.
* Reinforce patient education in order to improve knowledge and understanding of the medication prescribed.
* Ensure that both prescription medicines and OTC preparations are used appropriately.
* Facilitate the communication with other members of healthcare team in order to agree and implement measures to overcome medication related problems.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prioritising Patient Medication Review: Hospitals Reaching Out
NCT06451692
Reducing Post-discharge Potentially Inappropriate Medications Among Older Adults
NCT02918058
General Practitioner (GP) Practice Based Pharmacist Input to Medicines Optimisation
NCT03241498
Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention
NCT03272607
Polypharmacy Outpatient Clinic
NCT03911934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is widely accepted that a number of medication related problems can occur post discharge when complicated medication regimens can often prove confusing. This can lead to mismanagement of medicines and early rehospitalisation of patients. Although these problems are frequently commented upon, research in this area is still lacking. The present project aims to examine an extension of the present IMM service by evaluating the impact/patient benefit of a customised outpatient service provided by clinical pharmacy staff to patients post-discharge. An increase in patients' medicines adherence, a greater satisfaction with information about their medicines, improved beliefs about the necessity of their medicines, a decrease in medicines-related problems, a decrease in re-hospitalisation rates, extended time to re-hospitalisation, and a decrease in overall costs of patients care is anticipated.
This study will be carried out as a collaboration between the School of Pharmacy at Queen's University Belfast and the Northern Health and Social Care Trust (2 sites; Antrim Area Hospital and Whiteabbey Hospital).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Outpatient Medicine Management Clinic
Consented patients will attend two outpatient clinic appointments to receive help with any (potential) medicine-related problems
Medicines Management Outpatient service
New customised clinical pharmacy service (medicines management clinic and follow-up phone calls)
Control
Patients will receive the normal care provided by the hospital
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medicines Management Outpatient service
New customised clinical pharmacy service (medicines management clinic and follow-up phone calls)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prescribed five or more regular long term medications.
* Have three or more changes to medications during hospital stay.
* Past history of medication related problems.
* Patient referred to the medicines management clinic service by hospital doctor or clinical pharmacist due to concerns about ability to manage medicines in primary care.
Exclusion Criteria
* Palliative care patients
* Patients unable to give informed consent e.g. Alzheimer's Disease
* Patients unable to use telephone at home.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen's University, Belfast
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James McElnay
Chief Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James C McElnay, BSc, PhD
Role: STUDY_CHAIR
Queen's University, Belfast
Michael G Scott, BSc, PhD
Role: PRINCIPAL_INVESTIGATOR
Northern Health and Social Care Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northern Health and Social Care Trust
Antrim, Northern Ireland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QUB B11/34
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.